VEGFA and age-related macular degeneration: The efficacy of anti-VEGF therapy in ocular neovascularization was initially studied in an animal laser model and was then tested in two large, randomized double-masked human clinical trials that led to the US Food and Drug Administration approval of anti-VEGF therapy for CNV in AMD [16,20].